Rituximab as a First-line Treatment for Autoimmune Hemolytic Anemia in Multicentric Castleman's Disease. - Cáceres Medina JL; González Torres LA; Gamboa-Meza A; Cantu-Rodriguez OG (Cureus, 2024)